UBS Group »

Denali Therapeutics shares owned by UBS Group

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $6.2M 291k 21.46
2023-09-30 $2.3M 110k 20.63
2023-06-30 $3.9M 132k 29.51
2023-03-31 $2.9M 127k 23.04
2022-12-31 $3.3M 120k 27.81
2022-09-30 $1.3M 43k 30.68
2022-06-30 $189k 6.4k 29.61
2022-03-31 $1.3M 39k 32.24
2021-12-31 $4.1M 92k 44.63
2021-09-30 $3.3M 65k 50.42
2021-06-30 $191k 2.4k 78.38
2021-03-31 $1.7M 30k 57.11
2020-12-31 $485k 5.8k 83.68
2020-09-30 $224k 6.3k 35.86
2020-06-30 $65k 2.7k 24.29
2020-03-31 $207k 12k 17.53
2019-12-31 $41k 2.3k 17.86
2019-09-30 $73k 4.7k 15.33
2019-06-30 $89k 4.3k 20.85
2019-03-31 $93k 4.0k 23.25
2018-12-31 $1.6M 79k 20.69
2018-09-30 $196k 9.1k 21.59
2018-06-30 $139k 9.0k 15.39
2018-03-31 $215k 11k 19.66
2017-12-31 $3.0k 200 15.00